首页> 外文期刊>Transactions of the Royal Society of Tropical Medicine and Hygiene >Seropositivity to anti-phenolic glycolipid-I in leprosy cases, contacts and no known contacts of leprosy in an endemic and a non-endemic area in northeast Brazil
【24h】

Seropositivity to anti-phenolic glycolipid-I in leprosy cases, contacts and no known contacts of leprosy in an endemic and a non-endemic area in northeast Brazil

机译:血清阳性在麻风病例,与巴西东北地区的流行病和非流行区域中的胡萝卜素接触和没有已知的联系人

获取原文
获取原文并翻译 | 示例
           

摘要

The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups with differing exposure to Mycobacterium leprae in Ceará, Brazil were investigated between March 2005 and August 2006. The first three groups in a high prevalence area included 144 cases of leprosy, their 380 contacts and 317 participants with no known leprosy contact. The fourth group in a low prevalence area consisted of 87 participants with no known leprosy contact living in an area in which no cases of leprosy had been reported in the previous 6 months. Seropositivity and levels of IgM antibodies to PGL-I were investigated using ELISA. The seropositivity levels of anti-PGL-I among the different clinical forms of leprosy cases were 61% for lepromatous, 25% for tuberculoid and 27% indeterminate. The levels of anti-PGL-I antibodies in the endemic area differentiated leprosy cases from non-cases. However, the seropositivity was similar among contact cases (15.8%) and no known leprosy contact cases from high (15.1%) and low (13.8%) prevalence areas. The seropositivity of both contacts and no known contacts was much higher than previously reported among no known contacts in other endemic areas. The study indicates that anti-PGL-I antibodies are not useful as immunological markers of household leprosy contacts and no known leprosy contacts in endemic areas.
机译:在2005年3月和2006年3月在3月至2006年3月,在巴西研究了四种研究组中IgM抗酚醛糖脂-i(PGL-I)抗体的四种研究组抗体的抗体。 144例麻风病,他们的380次触点和317名参与者,没有已知的麻风病联系。低流行区域的第四组由87名参与者组成,没有已知的Leprosy接触,居住在一个地区,在过去的6个月内没有报告麻风病病例。使用ELISA研究了对PGL-I的IgM抗体的血清阳性和水平。抗PGL-1之间的血清阳性水平不同临床形式的麻风病病例为Lepromatous的61%,结核抑制症25%,27%不确定。抗PGL-1抗体在地方区域的抗体水平分化为不同病例的麻风病变案。然而,血清阳性在接触案件(15.8%)之间具有相似,并且没有高(15.1%)和低(13.8%)流行区域的已知的麻风病联接案例。触点和未知的触点的血液呈阳性远高于在其他地方区域中的任何已知接触中所报道的。该研究表明,抗PGL-I抗体没有用作家庭麻风病接触的免疫标志物,并且在流行区域中没有已知的麻风病接触。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号